Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.

Surowy HM, Sutter C, Mittnacht M, Klaes R, Schaefer D, Evers C, Burgemeister AL, Goehringer C, Dikow N, Heil J, Golatta M, Schott S, Schneeweiss A, Bugert P, Sohn C, Bartram CR, Burwinkel B.

Breast Cancer Res Treat. 2014 Jun;145(2):451-60. doi: 10.1007/s10549-014-2943-5. Epub 2014 Apr 12.

PMID:
24728577
2.

Mirror-image asymmetry in monozygotic twins with kabuki syndrome.

Riess A, Dufke A, Riess O, Beck-Woedl S, Fode B, Skladny H, Klaes R, Tzschach A.

Mol Syndromol. 2012 Aug;3(2):94-7. doi: 10.1159/000341251. Epub 2012 Jul 25.

3.

A palindrome-mediated recurrent translocation with 3:1 meiotic nondisjunction: the t(8;22)(q24.13;q11.21).

Sheridan MB, Kato T, Haldeman-Englert C, Jalali GR, Milunsky JM, Zou Y, Klaes R, Gimelli G, Gimelli S, Gemmill RM, Drabkin HA, Hacker AM, Brown J, Tomkins D, Shaikh TH, Kurahashi H, Zackai EH, Emanuel BS.

Am J Hum Genet. 2010 Aug 13;87(2):209-18. doi: 10.1016/j.ajhg.2010.07.002. Epub 2010 Jul 30.

4.

Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.

Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, Kisseljov F, Dürst M, Schneider A, von Knebel Doeberitz M.

Cancer Res. 2008 Jan 1;68(1):307-13. doi: 10.1158/0008-5472.CAN-07-2754.

5.

Molecular genetic analysis of NBS1 in German melanoma patients.

Meyer P, Stapelmann H, Frank B, Varon R, Burwinkel B, Schmitt C, Boettger MB, Klaes R, Sperling K, Hemminki K, Kammerer S.

Melanoma Res. 2007 Apr;17(2):109-16.

PMID:
17496786
6.

Trisomy 8q and partial trisomy 22 in a 43-year-old man with moderate intellectual disability, epilepsy and large cell non-Hodgkin lymphoma.

Helbig I, Wirtenberger M, Jauch A, Hager HD, Tariverdian G, Hemminki K, Burwinkel B, Klaes R.

Am J Med Genet A. 2006 Aug 1;140(15):1658-62.

PMID:
16838305
7.

Polymorphisms in genes involved in GH1 release and their association with breast cancer risk.

Wagner K, Hemminki K, Grzybowska E, Klaes R, Burwinkel B, Bugert P, Schmutzler RK, Wappenschmidt B, Butkiewicz D, Pamula J, Pekala W, Försti A.

Carcinogenesis. 2006 Sep;27(9):1867-75. Epub 2006 Apr 10.

PMID:
16606630
8.

Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer.

Wirtenberger M, Frank B, Hemminki K, Klaes R, Schmutzler RK, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D, Bartram CR, Burwinkel B.

Carcinogenesis. 2006 Aug;27(8):1655-60. Epub 2006 Feb 25.

PMID:
16501249
9.

Association of prolactin and its receptor gene regions with familial breast cancer.

Vaclavicek A, Hemminki K, Bartram CR, Wagner K, Wappenschmidt B, Meindl A, Schmutzler RK, Klaes R, Untch M, Burwinkel B, Försti A.

J Clin Endocrinol Metab. 2006 Apr;91(4):1513-9. Epub 2006 Jan 24.

PMID:
16434456
10.

The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer.

Wilkening S, Bermejo JL, Burwinkel B, Klaes R, Bartram CR, Meindl A, Bugert P, Schmutzler RK, Wappenschmidt B, Untch M, Hemminki K, Försti A.

Cancer Res. 2006 Jan 15;66(2):646-8.

11.

Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer.

Frank B, Hemminki K, Wappenschmidt B, Klaes R, Meindl A, Schmutzler RK, Bugert P, Untch M, Bartram CR, Burwinkel B.

Int J Cancer. 2006 Jun 1;118(11):2917-8. No abstract available.

12.

Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.

Vinokurova S, Wentzensen N, Einenkel J, Klaes R, Ziegert C, Melsheimer P, Sartor H, Horn LC, Höckel M, von Knebel Doeberitz M.

J Natl Cancer Inst. 2005 Dec 21;97(24):1816-21.

PMID:
16368943
13.

Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.

Frank B, Hemminki K, Meindl A, Wappenschmidt B, Klaes R, Schmutzler RK, Untch M, Bugert P, Bartram CR, Burwinkel B.

Int J Cancer. 2006 May 15;118(10):2505-8.

14.

Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.

Wagner K, Hemminki K, Israelsson E, Grzybowska E, Klaes R, Chen B, Butkiewicz D, Pamula J, Pekala W, Försti A.

Endocr Relat Cancer. 2005 Dec;12(4):917-28.

PMID:
16322331
15.

Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.

Frank B, Hemminki K, Wappenschmidt B, Meindl A, Klaes R, Schmutzler RK, Bugert P, Untch M, Bartram CR, Burwinkel B.

Carcinogenesis. 2006 Mar;27(3):606-9. Epub 2005 Oct 26.

PMID:
16251207
16.

Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancer.

Wirtenberger M, Tchatchou S, Hemminki K, Klaes R, Schmutzler RK, Bermejo JL, Chen B, Wappenschmidt B, Meindl A, Bartram CR, Burwinkel B.

Carcinogenesis. 2006 Mar;27(3):593-8. Epub 2005 Oct 18.

PMID:
16234258
17.

Familial cancer and ARLTS1.

Frank B, Klaes R, Burwinkel B.

N Engl J Med. 2005 Jul 21;353(3):313-4; author reply 313-4. No abstract available.

PMID:
16038057
18.

Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer.

Frank B, Bermejo JL, Hemminki K, Klaes R, Bugert P, Wappenschmidt B, Schmutzler RK, Burwinkel B.

J Natl Cancer Inst. 2005 Jul 6;97(13):1012; author reply 1012-3. No abstract available.

PMID:
15998955
19.

TP53-binding protein variants and breast cancer risk: a case-control study.

Frank B, Hemminki K, Bermejo JL, Klaes R, Bugert P, Wappenschmidt B, Schmutzler RK, Burwinkel B.

Breast Cancer Res. 2005;7(4):R502-5. Epub 2005 May 6.

20.

Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.

Frank B, Hemminki K, Shanmugam KS, Meindl A, Klaes R, Schmutzler RK, Wappenschmidt B, Untch M, Bugert P, Bartram CR, Burwinkel B.

Carcinogenesis. 2005 Nov;26(11):1975-7. Epub 2005 Jun 23.

PMID:
15975957
21.

c-MYC Asn11Ser is associated with increased risk for familial breast cancer.

Wirtenberger M, Hemminki K, Försti A, Klaes R, Schmutzler RK, Grzybowska E, Bermejo JL, Wappenschmidt B, Bugert P, Butkiewicz D, Pamula J, Pekala W, Zientek H, Bartram CR, Burwinkel B.

Int J Cancer. 2005 Nov 20;117(4):638-42.

22.

Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.

Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Hallmans G, Försti A.

Clin Cancer Res. 2005 May 15;11(10):3647-53.

23.

Association of NCOA3 polymorphisms with breast cancer risk.

Burwinkel B, Wirtenberger M, Klaes R, Schmutzler RK, Grzybowska E, Försti A, Frank B, Bermejo JL, Bugert P, Wappenschmidt B, Butkiewicz D, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E, Bartram CR, Hemminki K.

Clin Cancer Res. 2005 Mar 15;11(6):2169-74.

24.

Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer.

Wilkening S, Burwinkel B, Grzybowska E, Klaes R, Pamula J, Pekala W, Zientek H, Hemminki K, Försti A.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):291-2. No abstract available.

25.

The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk.

Frank B, Hemminki K, Wirtenberger M, Bermejo JL, Bugert P, Klaes R, Schmutzler RK, Wappenschmidt B, Bartram CR, Burwinkel B.

Carcinogenesis. 2005 Mar;26(3):643-7. Epub 2004 Nov 18.

PMID:
15550452
26.

Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families.

Hartmann C, John AL, Klaes R, Hofmann W, Bielen R, Koehler R, Janssen B, Bartram CR, Arnold N, Zschocke J.

Hum Mutat. 2004 Dec;24(6):534.

PMID:
15532023
27.

The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer.

Wagner K, Hemminki K, Grzybowska E, Klaes R, Butkiewicz D, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E, Försti A.

Carcinogenesis. 2004 Dec;25(12):2473-8. Epub 2004 Aug 12.

PMID:
15308584
28.

Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers.

Jin Q, Hemminki K, Grzybowska E, Klaes R, Söderberg M, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Pamula J, Pekala W, Försti A.

Int J Cancer. 2004 Oct 20;112(1):94-9.

29.

Re: Integrin beta3 Leu33Pro homozygosity and risk of cancer.

Jin Q, Hemminki K, Grzybowska E, Klaes R, Söderberg M, Försti A.

J Natl Cancer Inst. 2004 Feb 4;96(3):234-5; author reply 235. No abstract available.

PMID:
14759991
30.

Breast cancer in young women (< or = 35 years): Genomic aberrations detected by comparative genomic hybridization.

Weber-Mangal S, Sinn HP, Popp S, Klaes R, Emig R, Bentz M, Mansmann U, Bastert G, Bartram CR, Jauch A.

Int J Cancer. 2003 Nov 20;107(4):583-92.

31.

Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.

Meyer P, Voigtlaender T, Bartram CR, Klaes R.

Hum Mutat. 2003 Sep;22(3):259.

PMID:
12938098
32.

Induction of antibodies to the PreS region of surface antigens of woodchuck hepatitis virus (WHV) in chronic carrier woodchucks by immunizations with WHV surface antigens.

Lu M, Klaes R, Menne S, Gerlich W, Stahl B, Dienes HP, Drebber U, Roggendorf M.

J Hepatol. 2003 Sep;39(3):405-13.

PMID:
12927927
33.

Exclusion of BRAFV599E as a melanoma susceptibility mutation.

Meyer P, Klaes R, Schmitt C, Boettger MB, Garbe C.

Int J Cancer. 2003 Aug 10;106(1):78-80.

34.

Identification and characterization of UEV3, a human cDNA with similarities to inactive E2 ubiquitin-conjugating enzymes.

Kloor M, Bork P, Duwe A, Klaes R, von Knebel Doeberitz M, Ridder R.

Biochim Biophys Acta. 2002 Dec 12;1579(2-3):219-24.

PMID:
12427560
35.

p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia.

Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, von Knebel Doeberitz M.

Am J Surg Pathol. 2002 Nov;26(11):1389-99.

PMID:
12409715
36.

Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions.

Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, Doeberitz Mv.

Oncogene. 2002 Jan 17;21(3):419-26.

37.
38.

[Status of the human DNA papillomavirus in cervical tumors].

Kiselev FL, Kiseleva NP, Kobzeva VK, Gritsko TM, Semenova LA, Pavlova LS, Klaes R, von Knebel Doeberitz M.

Mol Biol (Mosk). 2001 May-Jun;35(3):470-6. Russian.

PMID:
11443929
39.

Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri.

Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M.

Int J Cancer. 2001 Apr 15;92(2):276-84.

40.

Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells.

Luft F, Klaes R, Nees M, Dürst M, Heilmann V, Melsheimer P, von Knebel Doeberitz M.

Int J Cancer. 2001 Apr 1;92(1):9-17.

41.

Transvenous embolization of a dural arteriovenous fistula of the anterior cranial fossa: preliminary results.

Defreyne L, Vanlangenhove P, Vandekerckhove T, Deschrijver I, Sieben G, Klaes R, Kunnen M.

AJNR Am J Neuroradiol. 2000 Apr;21(4):761-5.

42.

Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.

Kienle P, Weitz J, Klaes R, Koch M, Benner A, Lehnert T, Herfarth C, von Knebel Doeberitz M.

Arch Surg. 2000 Feb;135(2):213-8.

PMID:
10668884
43.

Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes.

Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, Lotz B, Melsheimer P, von Knebel Doeberitz M.

Cancer Res. 1999 Dec 15;59(24):6132-6.

44.

Significant increase of a specific variant TSG101 transcript during the progression of cervical neoplasia.

Klaes R, Kloor M, Willeke F, Melsheimer P, von Knebel Doeberitz M, Ridder R.

Eur J Cancer. 1999 May;35(5):733-7.

PMID:
10505033
45.

Occipital pain in osteoid osteoma of the atlas. A report of two cases.

De Praeter MP, Dua GF, Seynaeve PC, Vermeersch DG, Klaes RL.

Spine (Phila Pa 1976). 1999 May 1;24(9):912-4.

PMID:
10327515
46.

Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical scrapes.

Nindl I, Jacobs M, Walboomers JM, Meijer CJ, Pfister H, Wieland U, Meyer T, Stockfleth E, Klaes R, von Knebel Doeberitz M, Schneider A, Duerst M.

Int J Cancer. 1999 May 17;81(4):666-8. No abstract available.

47.

No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer.

Klaes R, Ridder R, Schaefer U, Benner A, von Knebel Doeberitz M.

J Mol Med (Berl). 1999 Feb;77(2):299-302.

PMID:
10023783
48.

Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.

Willeke F, Ridder R, Bork P, Klaes R, Mechtersheimer G, Schwarzbach M, Zimmer D, Kloor M, Lehnert T, Herfarth C, von Knebel Doeberitz M.

Mol Carcinog. 1998 Dec;23(4):195-200.

PMID:
9869447
49.

High cervical pain and impairment of skull mobility as the only symptoms of an occipital condyle fracture. Case report.

Stroobants J, Fidlers L, Storms JL, Klaes R, Dua G, Van Hoye M.

J Neurosurg. 1994 Jul;81(1):137-8.

PMID:
8207517
50.

A cauda equina syndrome in a patient treated with oral anticoagulants. Case report.

Willems J, Anné A, Herregods P, Klaes R, Chappel R.

Paraplegia. 1994 Apr;32(4):277-80.

Supplemental Content

Support Center